-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on QuidelOrtho, Lowers Price Target to $17

Benzinga·04/10/2026 18:08:44
Listen to the news
UBS analyst Lu Li maintains QuidelOrtho (NASDAQ:QDEL) with a Neutral and lowers the price target from $30 to $17.